Global Health Ltd
BSE:543654
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Global Health Ltd
BSE:543654
|
IN |
|
Prosus NV
OTC:PROSF
|
NL |
|
Ajinomoto Co Inc
TSE:2802
|
JP |
|
U
|
Universal Music Group NV
OTC:UMGNF
|
NL |
|
Kroger Co
NYSE:KR
|
US |
|
S
|
Sealed Air Corp
SWB:SDA
|
US |
Wall St Price Targets
MEDANTA Price Targets Summary
Global Health Ltd
According to Wall Street analysts, the average 1-year price target for MEDANTA is 1 423.56 INR with a low forecast of 1 210.58 INR and a high forecast of 1 646.57 INR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MEDANTA's stock price target?
Price Target
1 423.56
INR
According to Wall Street analysts, the average 1-year price target for MEDANTA is 1 423.56 INR with a low forecast of 1 210.58 INR and a high forecast of 1 646.57 INR.
What is the Revenue forecast for Global Health Ltd?
Projected CAGR
17%
Over the last 4 years, the compound annual growth rate for Revenue has been 26%. The projected CAGR for the next 4 years is 17%.
What is the Gross Profit forecast for Global Health Ltd?
Projected CAGR
17%
Over the last 4 years, the compound annual growth rate for Gross Profit has been 27%. The projected CAGR for the next 4 years is 17%.
What is the Operating Income forecast for Global Health Ltd?
Projected CAGR
17%
Over the last 4 years, the compound annual growth rate for Operating Income has been 76%. The projected CAGR for the next 4 years is 17%.
What is the Pre-Tax Income forecast for Global Health Ltd?
Projected CAGR
21%
Over the last 4 years, the compound annual growth rate for Pre-Tax Income has been 111%. The projected CAGR for the next 3 years is 21%.
What is the Net Income forecast for Global Health Ltd?
Projected CAGR
19%
Over the last 4 years, the compound annual growth rate for Net Income has been 102%. The projected CAGR for the next 4 years is 19%.
